Inhalation Therapy; Complications
Conditions
Keywords
nebuliser, inhalers, dyspnea, anxiety level
Brief summary
Nebul Therapy is very effective in quickly improving the symptoms of respiratory system diseases. While applying this treatment, patients are expected to complete a sufficient period of time. However, this waiting and the symptoms of the disease may cause anxiety in the patient. The aim of the study was to enable patients to spend their nebul period actively by using a stress ball. Thus, it was thought that it would make a positive contribution to dyspnea severity and anxiety levels. The main questions it aims to answer are: Does using a stress ball contribute positively to nebulizer usage time? Is the use of a stress ball effective in reducing the severity of dyspnea? Is using a stress ball effective in reducing anxiety levels? For this purpose, participants will be asked to tighten and loosen the stress ball with one hand during the nebuliser therapy. They will be expected to continue this with at least two nebuliser therapy per day. A control group will be used to determine the effectiveness of the stress ball. This group will not use a stress ball while receiving nebulizer treatment.
Interventions
DEVICEStress ball
Stress balls are soft sponges with a diameter of 2-4 cm. The lightest starting level was preferred for the patients. Patients were allowed to take the stress ball in any hand they wanted. They were asked to squeeze and loosen the ball in their palm at 2-3 second intervals.
Sponsors
Kirsehir Ahi Evran Universitesi
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Intervention model description
randomized controlled trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hospitalized for at least three days * Having nebulizer treatment at least twice a day * Medicines that have the same effect as prescribed (bronchodilators) * Patients who are required to have at least 4 ml of medication in the reservoir * Patients who have previous experience of using a nebulizer at home
Exclusion criteria
* Those who have severe exacerbation attacks * People with speech problems * People who experience severe dyspnea due to heart disease * Those with high anxiety levels for any reason (death of a relative, etc.) * Those with muscle or nerve problems in their hands * Those who did not consent to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| dyspnea severity | Through study completion, an average of 4 months. | The patient's current dyspnea level is evaluated between 0-10. As it approaches 10, the intensity increases. The patient's dyspnea severity will be recorded before and after nebuliser therapy. This process will be done once. |
| anxiety levels | Through study completion, an average of 4 months. | describes the patient's current anxiety level. The patient's current anxiety level is determined with the state anxiety scale developed for this purpose. The patient's anxiety levels will be recorded before and after nebuliser therapy. This process will be done once. |
| treatment duration | Through study completion, an average of 4 months. | Defines the time between the start and end of nebuliser therapy. It is expected to be approximately 15-20 minutes. The patient's current condition will be measured. For this reason, it will be applied once. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Vital signs: Respiratory rate | Through study completion, an average of 4 months. | These are measurements that include the patient's respiratory rate. The patient's respiratory rate will be recorded before and after nebuliser therapy. This process will be done once. |
| saturation | Through study completion, an average of 4 months. | It is the percentage of oxygen saturation of the blood. Measured with a probe from the finger. The patient's saturation levels will be recorded before and after nebuliser therapy. This process will be done once. |
| Vital signs: Pulse | Through study completion, an average of 4 months. | These are measurements that include the patient's pulse. The patient's vital signs will be recorded before and after nebuliser therapy. This process will be done once. |
| Vital signs: Blood pressure | Through study completion, an average of 4 months. | These are measurements that include the patient's blood pressure. The patient's vital signs will be recorded before and after nebuliser therapy. This process will be done once. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactYasemin CEYHAN, PhD
Backup ContactYasemin CEYHAN
Outcome results
None listed